Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 102

1.

Biologics in the treatment of diffuse interstitial lung disease associated with connective tissue disease.

Alonso T, Castañeda S, Ancochea J.

Arch Bronconeumol. 2018 Jul 13. pii: S0300-2896(18)30273-4. doi: 10.1016/j.arbres.2018.06.008. [Epub ahead of print] English, Spanish. No abstract available.

2.

Importance of early diagnosis and treatment in idiopathic pulmonary fibrosis.

Molina-Molina M, Aburto M, Acosta O, Ancochea J, Rodríguez-Portal JA, Sauleda J, Lines C, Xaubet A.

Expert Rev Respir Med. 2018 Jul;12(7):537-539. doi: 10.1080/17476348.2018.1472580. Epub 2018 May 7. No abstract available.

PMID:
29718749
3.

Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial.

Ancochea J, García-Río F, Vázquez-Espinosa E, Hernando-Sanz A, López-Yepes L, Galera-Martínez R, Peces-Barba G, Pérez-Warnisher MT, Segrelles-Calvo G, Zamarro C, González-Ponce P, Ramos MI, Conforto JI, Jafri S, Soriano JB.

Eur Respir J. 2018 May 30;51(5). pii: 1800354. doi: 10.1183/13993003.00354-2018. Print 2018 May. No abstract available.

PMID:
29599185
4.

Interstitial pneumonia with autoimmune features: An update.

Valenzuela C, Cottin V, Ancochea J.

Arch Bronconeumol. 2018 Sep;54(9):447-448. doi: 10.1016/j.arbres.2018.02.003. Epub 2018 Mar 16. English, Spanish. No abstract available.

5.

Creation of the SAQ-COPD Questionnaire to Determine Physical Activity in COPD Patients in Clinical Practice.

Soler-Cataluña JJ, Puente Maestu L, Román-Rodríguez M, Esteban C, Gea J, Bernabeu Mora R, Pleguezuelos Cobo E, Ancochea J, Monteagudo Ruiz G, Garcia Rio F.

Arch Bronconeumol. 2018 Sep;54(9):467-475. doi: 10.1016/j.arbres.2018.01.016. Epub 2018 Mar 13. English, Spanish.

6.

COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD.

Kessler R, Casan-Clara P, Koehler D, Tognella S, Viejo JL, Dal Negro RW, Díaz-Lobato S, Reissig K, Rodríguez González-Moro JM, Devouassoux G, Chavaillon JM, Botrus P, Arnal JM, Ancochea J, Bergeron-Lafaurie A, De Abajo C, Randerath WJ, Bastian A, Cornelissen CG, Nilius G, Texereau JB, Bourbeau J.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701612. doi: 10.1183/13993003.01612-2017. Print 2018 Jan.

PMID:
29326333
7.

Does The Impact Of Cough On Quality Of Life In Bronchiectasis Depend On Prognosis?

Girón Moreno RM, Sánchez Azofra A, Aldave Orzaiz B, Pastor Sanz MT, Ancochea J.

Arch Bronconeumol. 2018 Apr;54(4):238-239. doi: 10.1016/j.arbres.2017.10.011. Epub 2017 Dec 14. English, Spanish. No abstract available.

8.

Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis.

Miravitlles M, Urrutia G, Mathioudakis AG, Ancochea J.

Respir Res. 2017 Nov 25;18(1):196. doi: 10.1186/s12931-017-0683-x. Review.

9.

A simple algorithm for the identification of clinical COPD phenotypes.

Burgel PR, Paillasseur JL, Janssens W, Piquet J, Ter Riet G, Garcia-Aymerich J, Cosio B, Bakke P, Puhan MA, Langhammer A, Alfageme I, Almagro P, Ancochea J, Celli BR, Casanova C, de-Torres JP, Decramer M, Echazarreta A, Esteban C, Gomez Punter RM, Han MK, Johannessen A, Kaiser B, Lamprecht B, Lange P, Leivseth L, Marin JM, Martin F, Martinez-Camblor P, Miravitlles M, Oga T, Sofia Ramírez A, Sin DD, Sobradillo P, Soler-Cataluña JJ, Turner AM, Verdu Rivera FJ, Soriano JB, Roche N; Initiatives BPCO, EABPCO, Leuven and 3CIA study groups.

Eur Respir J. 2017 Nov 2;50(5). pii: 1701034. doi: 10.1183/13993003.01034-2017. Print 2017 Nov.

PMID:
29097431
10.

Erratum to "Guidelines for the medical treatment of idiopathic pulmonary fibrosis" <[Arch Bronconeumol. 53 (2017) 263-9] >.

Xaubet A, Molina-Molina M, Acosta O, Bollo E, Castillo D, Fernández-Fabrellas E, Rodríguez-Portal JA, Valenzuela C, Ancochea J.

Arch Bronconeumol. 2017 Nov;53(11):657-658. doi: 10.1016/j.arbres.2017.06.010. Epub 2017 Sep 18. English, Spanish. No abstract available.

11.

Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study.

Horner A, Soriano JB, Puhan MA, Studnicka M, Kaiser B, Vanfleteren LEGW, Gnatiuc L, Burney P, Miravitlles M, García-Rio F, Ancochea J, Menezes AM, Perez-Padilla R, Montes de Oca M, Torres-Duque CA, Caballero A, González-García M, Buist S, Flamm M, Lamprecht B; BOLD Collaborative Research Group; EPI-SCAN Team; PLATINO Team; PREPOCOL Study Group.

Respir Res. 2017 Aug 23;18(1):162. doi: 10.1186/s12931-017-0643-5.

12.

Maxillomandibular advancement as the initial treatment of obstructive sleep apnoea: Is the mandibular occlusal plane the key?

Rubio-Bueno P, Landete P, Ardanza B, Vázquez L, Soriano JB, Wix R, Capote A, Zamora E, Ancochea J, Naval-Gías L.

Int J Oral Maxillofac Surg. 2017 Nov;46(11):1363-1371. doi: 10.1016/j.ijom.2017.07.003. Epub 2017 Jul 29.

PMID:
28760319
13.

Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase.

Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, Trigueros JA, Cosío BG, Casanova C, Antonio Riesco J, Simonet P, Rigau D, Soriano JB, Ancochea J.

Arch Bronconeumol. 2017 Jun;53(6):324-335. doi: 10.1016/j.arbres.2017.03.018. Epub 2017 May 3. English, Spanish.

14.

Sex bias in diagnostic delay in bronchiectasis: An analysis of the Spanish Historical Registry of Bronchiectasis.

Girón RM, de Gracia Roldán J, Olveira C, Vendrell M, Martínez-García MÁ, de la Rosa D, Máiz L, Ancochea J, Vázquez L, Borderías L, Polverino E, Martínez-Moragón E, Rajas O, Soriano JB.

Chron Respir Dis. 2017 Nov;14(4):360-369. doi: 10.1177/1479972317702139. Epub 2017 Apr 10.

15.

Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: Importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio.

Curbelo J, Luquero Bueno S, Galván-Román JM, Ortega-Gómez M, Rajas O, Fernández-Jiménez G, Vega-Piris L, Rodríguez-Salvanes F, Arnalich B, Díaz A, Costa R, de la Fuente H, Lancho Á, Suárez C, Ancochea J, Aspa J.

PLoS One. 2017 Mar 16;12(3):e0173947. doi: 10.1371/journal.pone.0173947. eCollection 2017.

16.

Guidelines for the medical treatment of idiopathic pulmonary fibrosis.

Xaubet A, Molina-Molina M, Acosta O, Bollo E, Castillo D, Fernández-Fabrellas E, Rodríguez-Portal JA, Valenzuela C, Ancochea J.

Arch Bronconeumol. 2017 May;53(5):263-269. doi: 10.1016/j.arbres.2016.12.011. Epub 2017 Mar 11. English, Spanish. Erratum in: Arch Bronconeumol. 2017 Nov;53(11):657-658.

17.

Idiopathic pulmonary fibrosis.

Xaubet A, Ancochea J, Molina-Molina M.

Med Clin (Barc). 2017 Feb 23;148(4):170-175. doi: 10.1016/j.medcli.2016.11.004. Epub 2016 Dec 18. Review. English, Spanish.

PMID:
27998476
18.

Identification of non-coding genetic variants in samples from hypoxemic respiratory disease patients that affect the transcriptional response to hypoxia.

Roche O, Deguiz ML, Tiana M, Galiana-Ribote C, Martinez-Alcazar D, Rey-Serra C, Ranz-Ribeiro B, Casitas R, Galera R, Fernández-Navarro I, Sánchez-Cuéllar S, Bernard V, Ancochea J, Wasserman WW, García-Rio F, Jimenez B, Del Peso L.

Nucleic Acids Res. 2016 Nov 2;44(19):9315-9330. Epub 2016 Sep 12.

19.

Role Of Hif2α Oxygen Sensing Pathway In Bronchial Epithelial Club Cell Proliferation.

Torres-Capelli M, Marsboom G, Li QO, Tello D, Rodriguez FM, Alonso T, Sanchez-Madrid F, García-Rio F, Ancochea J, Aragonés J.

Sci Rep. 2016 May 6;6:25357. doi: 10.1038/srep25357.

20.

Lung function testing in idiopathic pulmonary fibrosis: More than just spirometry?

Casan Clarà P, Martínez González C, Ancochea J.

Arch Bronconeumol. 2016 Sep;52(9):457-8. doi: 10.1016/j.arbres.2016.02.017. Epub 2016 Apr 14. English, Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center